Drugs Information: Ranibizumab (ophthalmic)
Basic Information
|
||
| ID | DDInter1567 | |
| Drug Type | biotech | |
| Molecular Formula | C2158H3282N562O681S12 | |
| Molecular Weight | - | |
| Description | Ranibizumab is a recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. | |
| ATC Classification | S01LA04 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Ranibizumab (ophthalmic)
| Severity level | ID | Name | Mechanism | Detail |
|---|